Diagnosis
Erythema multiforme
An self-limiting immune-mediated hypersensitivity reaction affecting both the skin (target lesions on the extremities) and mucous membranes (eyes, mouth, or genitals).
Etiology
Cause [ugn][fnf][kqq]
Virus:
HSV-1, HSV-2, EBV, CMV, VZV, Adenovirus, Coxsackievirus, Echovirus, Hepatitis, Orf, Enterovirus, Hepatitis A/B/C viruses, Influenza, Measles, Mumps, Parvovirus B19, Poliomyelitis, HIV
Bacteria:
Mycoplasma pneumoniae, Corynebacterium diphtheriae, Hemolytic streptococci, Legionella pneumophila, Salmonella, Mycobacterium leprae, Pneumococcus, Borreliosis, Catscratch disease, Diphtheria, Legionellosis, Hemolytic streptococci, Staphylococcus, Leprosy, Salmonellosis, Neisseria meningitidis, Mycobacterium avium complex, Pneumococci, Tuberculosis, Treponema avium complex, pneumococci, tuberculosis, Treponema pallidum, tularemia, and rickettsia
Fungus: Histoplasmosis
Parasites
Immune disease:
Graft versus host disease, Inflammatory bowel disease, Polyarteritis nodosa, Sarcoidosis, Systemic lupus erythematous, Vaccines (Diphtheria-tetanus-pertussis, Measles-mumps-rubella, Bacille Calmette-Guerin, hepatitis B and smallpox)
Drugs:
Trimethoprim, sulfamethoxazole, NSAIDs, Penicillins, Anticonvulsants (barbiturates, carbamazepine), Hydantoids, Valproic acid, Allopurinol, Antifungal (Terbinafine), Oxicama (piroxicam, tenoxicam), Imidazole, Chlormezanone, Corticosteroids, Cephalosporins, Quinolones, Tetracycline, Aspirin, Nitrofurantoin, Diphtheria-tetanus-pertussis immunization, Measles-mumps-rubella vaccine
Pregnancy
Malignancy
Radiotherapy
Menstruation
Idiopathic
Pathophysiology [kqq]
Exact pathophysiology is unknown
Genetic susceptibility
Enviromental trigger
Cell-mediated immune response against antigens in skin lesions
Influx of macrophages and CD8 T lymphocytes
Release of cytokines --> inflammation --> cell death
Steven-Johnson Syndrome and toxic epidermal necrolysis are severe variant of Erythema multiforme associated with drug therapies.
Complications [kqq]
Strictures of the urethra, esophagus, vagina, and anus
Eye complications: Uveitis, conjunctivitis, scarring, panophthalmitis, blindness, piphora
Epidemiology
Incidence per 100.000 [fnf]
Symptoms & findings
Symptoms
Arthralgia, Cough, Fever, Headache, Malaise, Myalgia, Nausea, Sore throat
Clinical findings
None listed.
Anamneses
None listed.
Localized findings
Approach
Dermatoscopy (clinical diagnosis)
Blood test: Complete blood cell count, Erythrocyte sedimentation
Skin biopsy:
Immunofluorescence study: Specific HSV antigens within keratinocytes
Polymerase chain reaction: HSV DNA primarily within the keratinocytes
Chest x-ray
Erythema Multiforme
Target lesions <3cm in diameter
No or only 1 mucous membrane involvement
<20% body are involved
Biopsy compatible with Erythema Multiforme (PCR --> Herpes Simpex DNA?)
Stevens-Johnson syndrome
Target lesions <3cm in diameter
2 or more mucous membrane involvement
Fever
10-20% body are involved
Biopsy compatible with Erythema Multiforme
Toxic Epidermal Necrolysis
Bullae and/or erosions >3cm in diameter with erythema and desquamation as seen in exfoliative erythroderma
Frequent mucous membrane involvement
Fever
>20% body are involved
Biopsy compatible with drug-induced toxic epidermal necrolysis
Treatment
Acute phase --> Treat underlying disease: [kqq]
HSV infection: acyclovir 400 mg x 2 or valacyclovir 500 mg x 2
Mycoplasma pneumoniae infection
Drug-induced --> promptly discontinue
Mild case: Complete healing in 3-6 weeks and the disease may recur
Anti-inflammatory: Fluocinonide 0.05% or other topical steroid agents
Analgesic agents
Mouthwash containing lidocaine and diphenhydramine
Severe case:
Systemic steroids: Prednisone 40-60 mg/day, tapered over 2 to 4 weeks
Antiviral therapy (acyclovir, valacyclovir, or famciclovir)
Supportive care: liquid diet, intravenous fluids, electrolytes, and nutritional support
Differential diagnoses
Acute exanthematic pustulosis, Acute febrile neutrophilic dermatosis, Aphthous stomatitis, Behcet's disease, Bullous pemphigoid, Burn wound, Contact dermatitis, Drug eruptions, Erythroderma, Granuloma annulare, Herpes simplex, Lichen planus, Linear IgA dermatosis, Lyme disease, Meningitis, Mycoplasma infection, Necrotizing vasculitis, Pemphigus erythematosus, Pemphigus foliaceus, Pemphigus vulgaris, Pityriasis rosea, Sepsis, Serum sickness, Staphylococcal scalded skin syndrome, Stevens-Johnson syndrome, Syphilis, Systemic lupus erythematosus, Toxic epidermal necrolysis, Urticaria
References
[1] Samim F, Auluck A, Zed C, Williams PM. Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment. Dent Clin North Am. 2013 Oct;57(4):583-96.
[2] Chan HL, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H, Walker AM. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol. 1990 Jan;126(1):43-7.
[3] Hafsi W, Badri T. Erythema Multiforme. [Updated 2024 Oct 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470259/
[4] [Clinical Dermatology 4.th Edition by Weller, Hunter, Savin and Dahl]
[5] Hellgren L, Hersle K. Erythema multiforme: statistical eval- uation of clinical and laboratory data in 224 patients and matched healthy controls. Acta Allergologica. 1965;21:45-51.
[6] Ting HC, Adam BA. Erythema multiforme: epidemiology, clinical characteristics and natural history in fifty-nine patients. Australas J Dermatol. 1984;25:83-88.
[7] https://emedicine.medscape.com/article/1122915